The Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog remove…
What to know about CLX
The Clorox Company is a large Consumer Defensive company with a mixed financial profile. It scores well on valuation and profitability, but size is worth keeping an eye on.
Should you consider CLX?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
The Clorox Company is a large-cap Consumer Defensive company with a mixed overall financial profile — it ranks near the bottom of Consumer Defensive stocks (30 of 35).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
There is a small dividend (0.05%), but income-focused investors will likely find better yields elsewhere in the market.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
Analyst sentiment is cautious and short interest is relatively elevated — meaning some professional investors are actively betting the price will fall. Worth understanding why.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Consumer Defensive sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how CLX compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 15.58 | Top 25% |
| Forward P/E | 15.30 | Above avg |
| PEG Ratio | 2.21 | Average |
| Price to Sales | 1.71 | Top 25% |
| Price to Book | -172.92 | Top 25% |
| EV/EBITDA | 11.96 | Above avg |
| Earnings Yield | 6.42% | Top 25% |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 43.85% | Average |
| Operating Margin | 17.01% | Average |
| Net Profit Margin | 11.18% | Average |
| Return on Equity | 546.10% | Top 25% |
| Return on Invested Capital | 11.04% | Top 25% |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 0.10% | Below avg |
| Revenue Growth (3Y CAGR) | -0.01% | Below avg |
| EPS Growth (YoY) | 2.70% | Average |
| Free Cash Flow Growth | 57.56% | Top 25% |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 0.84 | Below avg |
| Debt to Equity | 48.76 | Below avg |
| Interest Coverage | 13.25 | Above avg |
| Altman Z-Score | 3.38 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 5.09% | Top 25% |
| Payout Ratio | 80.33% | Below avg |
| Dividend Growth (5Y) | -11.39% | Below avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 3.28% | Average |
| OCF to Sales | 8.52% | Below avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.55 | Top 25% |
| Volatility (30-Day) | 35.12% | Average |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 8.85% | Below avg |
| Avg. Analyst Rating | 3.11 | Below avg |
| Target Upside % | 9.91% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 11.58B | Below avg |
How does CLX compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to CLX — based on their financial profile.